199 related articles for article (PubMed ID: 37664132)
1. Differential Diagnosis of Tumor-like Brain Lesions.
Perez Giraldo GS; Singer L; Cao T; Jamshidi P; Dixit K; Kontzialis M; Castellani R; Pytel P; Anadani N; Bevan CJ; Grebenciucova E; Balabanov R; Cohen BA; Graham EL
Neurol Clin Pract; 2023 Oct; 13(5):e200182. PubMed ID: 37664132
[TBL] [Abstract][Full Text] [Related]
2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
3. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
4. Differential imaging of atypical demyelinating lesions of the central nervous system.
Paoletti M; Muzic SI; Marchetti F; Farina LM; Bastianello S; Pichiecchio A
Radiol Med; 2021 Jun; 126(6):827-842. PubMed ID: 33486703
[TBL] [Abstract][Full Text] [Related]
5. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
[TBL] [Abstract][Full Text] [Related]
6. The landscape of brain tumor mimics in neuro-oncology practice.
Yogendran LV; Kalelioglu T; Donahue JH; Ahmad H; Phillips KA; Calautti NM; Lopes MB; Asthagiri AR; Purow B; Schiff D; Patel SH; Fadul CE
J Neurooncol; 2022 Sep; 159(3):499-508. PubMed ID: 35857249
[TBL] [Abstract][Full Text] [Related]
7. Retinal vasculopathy with cerebral leukoencephalopathy (RVCL): A rare mimic of tumefactive MS.
Raynowska J; Miskin DP; Pramanik B; Asiry S; Anderson T; Boockvar J; Najjar S; Harel A
Neurology; 2018 Oct; 91(15):e1423-e1428. PubMed ID: 30194247
[TBL] [Abstract][Full Text] [Related]
8. Tumefactive demyelinating lesion: experience with two unusual patients.
Sinha MK; Garg RK; Bhatt ML; Chandra A
J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396
[TBL] [Abstract][Full Text] [Related]
9. Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.
Barbosa BC; Marchiori E; Leal Leidersnaider C; Brandao L; Castillo M
Neuroradiol J; 2019 Apr; 32(2):103-107. PubMed ID: 30667319
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature.
Vakrakou AG; Tzanetakos D; Argyrakos T; Koutsis G; Evangelopoulos ME; Andreadou E; Anagnostouli M; Breza M; Tzartos JS; Gialafos E; Dimitrakopoulos AN; Velonakis G; Toulas P; Stefanis L; Kilidireas C
Front Neurol; 2020; 11():536. PubMed ID: 32714265
[TBL] [Abstract][Full Text] [Related]
11. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Pseudotumoral Central Nervous System Lesions in an Oncology Center.
Torres YC; Alves-Leon SV; Lima MA
World Neurosurg; 2019 Oct; 130():e333-e337. PubMed ID: 31228702
[TBL] [Abstract][Full Text] [Related]
13. Tumefactive Demyelination Appearing as Multiple Cystic Brain Lesions.
Wynne D; Hung Ho BK; Han TF
World Neurosurg; 2021 Sep; 153():6-8. PubMed ID: 34129977
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic biopsy of non-neoplastic lesions in adults.
Whiting DM; Barnett GH; Estes ML; Sila CA; Rudick RA; Hassenbusch SJ; Lanzieri CF
Cleve Clin J Med; 1992; 59(1):48-55. PubMed ID: 1551214
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
Nazlı ŞB; Sevindik M
Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
[TBL] [Abstract][Full Text] [Related]
16. Tumefactive multiple sclerosis masquerade as a central nervous system tumor: a case report.
Turkistani AN; Alshamrani FJ; Shareefi GF; Alsulaiman A
Electron Physician; 2018 Aug; 10(8):7180-7184. PubMed ID: 30214700
[TBL] [Abstract][Full Text] [Related]
17. Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics.
Arenas Vargas LE; Bedoya Morales AM; Rincón Carreño C; Espitia Segura OM; Penagos N
Mult Scler Relat Disord; 2020 Sep; 44():102198. PubMed ID: 32531753
[TBL] [Abstract][Full Text] [Related]
18. Lesser-known myelin-related disorders: focal tumour-like demyelinating lesions.
Jiménez Arango JA; Uribe Uribe CS; Toro González G
Neurologia; 2015 Mar; 30(2):97-105. PubMed ID: 24094691
[TBL] [Abstract][Full Text] [Related]
19. Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome.
Hardy TA
Curr Opin Neurol; 2019 Jun; 32(3):467-474. PubMed ID: 30844860
[TBL] [Abstract][Full Text] [Related]
20. Tumefactive Multiple Sclerosis Variants: Report of Two Cases of Schilder and Balo Diseases.
Ashrafi MR; Tavasoli AR; Alizadeh H; Zare Noghabi J; Parvaneh N
Iran J Child Neurol; 2017; 11(2):69-77. PubMed ID: 28698732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
